Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity.
J Clin Invest. 2020 May 1;130(5):2209-2219. doi: 10.1172/JCI131126.
J Clin Invest. 2020.
PMID: 31961826
Free PMC article.
Clinical Trial.